Tissue repair: why more collagen does not necessarily mean better healing

Healing integrates clotting, immune activity, cell growth, and matrix remodeling. Evaluating a proposed repair therapy requires matching its evidence to the type of injury and the outcome that matters.

Overlapping phases

The classic model divides wound healing into hemostasis, inflammation, proliferation, and remodeling. It is useful for study, although tissue does not change phases like a switch. Different regions of the same wound can show simultaneous processes. The chronology depends on the tissue, the extent of the injury, and the patient's condition. When a wound fails to heal, it is important to identify which process is altered and why. It is not enough to attribute it to a lack of a molecular signal. Perfusion, infection, mechanical load, and systemic disease also modify the observed trajectory.

Hemostasis and the temporary matrix

Following vascular injury, hemostasis reduces blood loss and prepares the environment for repair. Platelets participate in clotting and release mediators. Fibrin contributes to a temporary matrix where cells and proteins subsequently interact. This support is not equivalent to the mature matrix that will bear loads. Nor does indiscriminately increasing coagulation necessarily improve healing. Biological processes require spatial and temporal regulation. An intervention that modifies a mediator must demonstrate that it improves a relevant outcome without introducing harm. This distinction will be important when reviewing molecules active in cell cultures, where much of the human vascular context is lacking. The experimental model remains part of the interpretation.

Inflammation in repair

Inflammation plays a role in the defense and cleanup of injured tissue. Neutrophils and macrophages help recognize threats, remove debris, and coordinate other cells. A persistent or dysregulated response can hinder wound healing. However, reducing any inflammatory signal does not guarantee better repair. Timing, intensity, and context are all important. It is advisable to avoid a rigid division between healthy and harmful cells. Their functional states change according to environmental stimuli. When evaluating a compound, a decrease in a cytokine represents a molecular finding. To confirm clinical benefit, we need to know about wound closure, pain, function, infections, and other relevant outcomes.

Proliferation

During proliferation, the activity of cells that repair the defect increases. Fibroblasts produce matrix components, while the epithelium advances to regain coverage. Vascular formation helps support the needs of the repairing tissue. Among the signals studied are platelet-derived factors and vascular growth factors. Identifying these signals explains biological possibilities, but does not automatically identify a treatment. An image showing more blood vessels does not necessarily indicate a stronger scar. Experiments must clarify which tissue they analyzed and how they measured the change. In humans, it is also important to determine whether the wound remains closed and whether the person resumes activities without significant complications.

Remodeling

The newly deposited matrix changes during remodeling. Components are reorganized, and synthesis and degradation processes are balanced. The total amount of collagen provides information, but it doesn't fully describe its orientation or mechanical properties. Two tissues can contain similar amounts and respond differently to a load. Therefore, a biochemical result cannot replace a functional assessment. We must also distinguish between sufficient repair and excessive fibrosis. The clinical goal is not to maximize all matrix production, but to restore integrity and function within the tissue's capabilities. This perspective allows for a more accurate interpretation of studies that report collagen stimulation. Organization and function therefore remain part of the assessment.

The person and the wound

Repair occurs within a person and their environment, not in an isolated culture. Insufficient perfusion limits the supply of resources. Infection can perpetuate damage and inflammation. Nutritional status and metabolic diseases influence the response. Pressure or repeated loading can impede tissue healing. These factors require specific evaluation, without assuming that all are present in every patient. Examination also distinguishes a skin wound from a tendon or muscle injury. Their needs are not identical. Before attributing slow healing to a lack of peptides, we must develop a verifiable clinical explanation. The assessment must identify which of these factors is actually relevant to the individual case.

Choosing the relevant outcome

A study might measure cell migration, matrix content, wound surface area, or walking ability. Each measurement answers a different question. The former help us understand mechanisms; the latter approach consequences that matter to the patient. No measurement is useless simply because it belongs to an early stage. The problem arises when we present one stage as evidence of another. The comparator, follow-up, and accompanying interventions also matter. A reduction in area during treatment does not prove that the treatment caused it. We need to assess what would have happened with comparable care. This reasoning will underpin all the tissue repair lessons in this module.

What to remember

Cell migration, collagen content, wound closure, and restored function are different outcomes. A positive result in one should not be presented as proof of all the others.

Continue with PEPTIDE Academy, Module 6. The complete lessons remain in the Academy; this public article introduces selected concepts.